This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these messages)
|
Christos Socrates Mantzoros | |
|---|---|
| | |
| Born | |
| Alma mater | |
| Occupations | Medical doctor and Professor at Harvard Medical School |
| Known for | Leptin, Adiponectin |
| Awards |
|
| Scientific career | |
| Fields | Endocrinology, Diabetes, Metabolism |
| Institutions | Harvard Medical School, Beth Israel Deaconess Medical Center |
| Website | www |
Christos Socrates Mantzoros is a Greek-born American internist-endocrinologist, teacher, and researcher. He is a professor of medicine at Harvard Medical School and an adjunct professor at Boston University School of Medicine. In the past he has also served as a professor at the Harvard T.H. Chan School of Public Health.
He is board certified in internal medicine and endocrinology & metabolism in both Europe and the United States and serves as the chief of endocrinology, diabetes, and metabolism at the VA Boston Healthcare System. He is also the founding director of human nutrition at Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School and editor-in-chief of the journal Metabolism: Clinical and Experimental . [1]
Mantzoros has served as a board member on the Hellenic College Holy Cross as well as the ALBA Graduate Business School of the American College of Greece board of trustees. [2]
Mantzoros researches topics such as human physiology and molecular biology, observational epidemiology studies, and clinical trials treating obesity, diabetes, and other human metabolic diseases. [3] Mantzoros is known for his work on leptin, adiponectin, and the proglucagon family of molecules, as well as the relationship between insulin-like growth factors (IGFs) and cancer. [3] Leptin has been approved by the United States Food and Drug Administration (FDA) for treating lipodystrophy and severe insulin resistance accompanied by hyperglycemia and hyperlipidemia. [3]
His publications include two books and more than 1100 scientific papers. [4] In addition to this he has run over 135 clinical trials. [4]
Mantzoros heads Mantzoros Consulting, LLC. In 2005, he co-founded Intekrin, Inc., which was later acquired by and merged with Coherus, Inc. [5]
Mantzoros teaches at Harvard Medical School and Boston University School of Medicine where he has mentored more than 200 scientists. [6]
Mantzoros teaches pro bono biomedical ethics at the Hellenic College and Holy Cross School of Theology[ citation needed ], serving on the Archdiocesan Advisory Council on Bioethics, and serving on the Hellenic College Holy Cross [ citation needed ], as well as the ALBA Graduate Business School of the American College of Greece board of trustees. [2]
Mantzoros has received the following awards:
Other (selected) awards include: